These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30804130)

  • 1. Breast Cancer in Lean Postmenopausal Women Might Have Specific Pathological Features.
    Uomori T; Horimoto Y; Arakawa A; Iijima K; Saito M
    In Vivo; 2019; 33(2):483-487. PubMed ID: 30804130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
    Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
    Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [EPIDEMIOLOGICAL FEATURES OF BREAST CANCER IN THE REPUBLIC OF UZBEKISTAN].
    Miryusupova GF; Khakimov GA; Shayusupov NR
    Vopr Onkol; 2016; 62(4):495-8. PubMed ID: 30475536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
    Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
    Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial polyps in obese asymptomatic pre and postmenopausal patients with breast cancer: is screening necessary?
    Lubián López DM; Orihuela López F; García-Berbel Molina L; Boza Novo P; Pozuelo Solís E; Menor Almagro D; Comino Delgado R
    Gynecol Oncol; 2014 Apr; 133(1):56-62. PubMed ID: 24680592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Obesity and the Risk of Breast Cancer among Pre and Postmenopausal Women.
    Gravena AAF; Romeiro Lopes TC; Demitto MO; Borghesan DHP; Dell’ Agnolo CM; Brischiliari SCR; Carvalho MDB; Pelloso SM
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2429-2436. PubMed ID: 30255696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.
    Wang F; Liu L; Cui S; Tian F; Fan Z; Geng C; Cao X; Yang Z; Wang X; Liang H; Wang S; Jiang H; Duan X; Wang H; Li G; Wang Q; Zhang J; Jin F; Tang J; Li L; Zhu S; Zuo W; Ma Z; Zhou F; Yu L; Xiang Y; Li L; Shen S; Yu Z
    Oncologist; 2017 Dec; 22(12):1431-1443. PubMed ID: 28912152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial.
    Knoop AS; Lænkholm AV; Jensen MB; Nielsen KV; Andersen J; Nielsen D; Ejlertsen B;
    Eur J Cancer; 2014 May; 50(8):1412-21. PubMed ID: 24675287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
    Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
    JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between body mass index and immunohistochemical subtypes in breast cancer.
    Sahin S; Erdem GU; Karatas F; Aytekin A; Sever AR; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():227-236. PubMed ID: 27756509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.
    Yamashita H; Ogiya A; Shien T; Horimoto Y; Masuda N; Inao T; Osako T; Takahashi M; Endo Y; Hosoda M; Ishida N; Horii R; Yamazaki K; Miyoshi Y; Yasojima H; Tomioka N;
    Breast Cancer; 2016 Nov; 23(6):830-843. PubMed ID: 26467036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers associated with breast cancer are associated with obesity.
    Sauter ER; Scott S; Hewett J; Kliethermes B; Ruhlen RL; Basarakodu K; de la Torre R
    Cancer Detect Prev; 2008; 32(2):149-55. PubMed ID: 18639389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibitors in obese breast cancer patients are not associated with increased plasma estradiol levels.
    Diorio C; Lemieux J; Provencher L; Hogue JC; Vachon E
    Breast Cancer Res Treat; 2012 Nov; 136(2):573-9. PubMed ID: 23053662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer risk and the interaction between adolescent body size and weight gain in later life: A case-control study.
    Florath I; Sarink D; Saunders C; Heyworth J; Fritschi L
    Cancer Epidemiol; 2016 Dec; 45():135-144. PubMed ID: 27810485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer in Tunisia: association of body mass index with histopathological aspects of tumors.
    Bouguerra H; Guissouma H; Labidi S; Stambouli N; Marrakchi R; Chouaib S; Ben Ammar Elgaaied A; Boussen H; Gati A
    Asian Pac J Cancer Prev; 2014; 15(16):6805-10. PubMed ID: 25169529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of dietary and genetic factors on metabolic status in obese and lean postmenopausal women.
    Milewicz A; Demissie M; Zatonska K; Jedrzejuk D; Tworowska U; Ilow R; Biernat J
    Gynecol Endocrinol; 2003 Aug; 17(4):333-8. PubMed ID: 14503979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients.
    Mazzarella L; Disalvatore D; Bagnardi V; Rotmensz N; Galbiati D; Caputo S; Curigliano G; Pelicci PG
    Eur J Cancer; 2013 Nov; 49(17):3588-97. PubMed ID: 23953055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index, age at breast cancer diagnosis, and breast cancer subtype: a cross-sectional study.
    Brouckaert O; Van Asten K; Laenen A; Soubry A; Smeets A; Nevelstreen I; Vergote I; Wildiers H; Paridaens R; Van Limbergen E; Weltens C; Moerman P; Floris G; Neven P;
    Breast Cancer Res Treat; 2018 Feb; 168(1):189-196. PubMed ID: 29159760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factors.
    Wasserman L; Flatt SW; Natarajan L; Laughlin G; Matusalem M; Faerber S; Rock CL; Barrett-Connor E; Pierce JP
    Int J Obes Relat Metab Disord; 2004 Jan; 28(1):49-56. PubMed ID: 14557830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.